Interestingly, blockade of NOTCH signalling with gamma-secretase inhibitor prevented the progression of premalignant pancreatic lesions to PDA in a mouse model of KRAS-induced PDA [10,11]. The gene discussed is KRAS; the disease is Patent ductus arteriosus.